Chinese stocks rose on Tuesday as Chinese commercial banks, under the guidance of the People's Bank of China, voted to retain the one-year loan prime rate for the ninth straight month.

The Shanghai Composite Index, the main gauge of Chinese stocks, rose 0.9%, or 35.34 points, to 4,117.41 points, while the Shenzhen Component Index added 1.4%, or 191.38 points, to 14,291.56.

The banks retained the one-year LPR at 3% on Tuesday, while the over-five-year LPR stayed at 3.5%.

Elsewhere, China could target an economic growth of around 5% for 2026, China Daily cited Zhang Liqun from the Development Research Center as saying.

Zhang added that the likely GDP growth target requires achieving more than standard stimulus, given the sustained period of modest price levels for both goods and capital.

In company news, Frontier Biotechnologies (SHA:688221) signed an exclusive worldwide licensing agreement with GlaxoSmithKline for two early-stage siRNA assets, securing an upfront payment of $40 million and a near-term milestone payment of $13 million. Shares of the biotechnology company closed 9% higher Tuesday.